Category: Biopharmaceuticals
Global Biopharmaceuticals
-
The 2025-2030 World Outlook for Erythropoietins
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cancer Biologics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Cold Chain Logistics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Excipients
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for PEGylated Proteins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Upstream Biopharmaceutical Fermentation Products
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Biologics Development and Manufacturing Testing
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals Contract Manufacturing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biologic Vasculitis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biologics Safety Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Biopharma
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2024-2032
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2024-2032 The global biosimilar market size reached US$ 21.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 164.5 Billion by 2032, exhibiting ... Read More
-
Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)
... has released a research report titled “Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)” which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market ... Read More
-
Global Biosimilars Market Growth 2024-2030
... forecast to a readjusted size of US$ 18570 million by 2030 with a CAGR of 18.7% during review period. The research report highlights the growth potential of the global Biosimilars market. Biosimilars are expected to ... Read More
-
Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030
... USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that ... Read More
-
Bevacizumab Biosimilars Global Market Report 2024
... Cervical Cancer; Ovarian Cancer Covering: Cipla Limited; Reliance lifesciences Pvt. Ltd.; Genentech Inc; Fujifilm Kyowa Kirin Biologics Co. Ltd.; Pfizer Inc. Bevacizumab Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Biosimilar Therapeutic Peptides Global Market Report 2024
... Disorders; Dermatology; Respiratory Disorders Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi SA Biosimilar Therapeutic Peptides Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Trastuzumab Biosimilars Global Market Report 2024
... Outlook Therapeutics lnc.; Merck & Co.; Amgen Inc.; BioXpress Therapeutics SA Trastuzumab Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Oral Biologics & Biosimilars Global Market Report 2024
... Disease 3) By Molecule Type: Vaccines; Proteins and Peptides; Monoclonal Antibodies Molecule Types 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Merck & Co. Inc.; GlaxoSmithKline; Novo Nordisk; ALK-Abelló; Aimmune Therapeutics Inc. ... Read More
-
Rituximab Biosimilars Global Market Report 2024
... Order Covering: Teva/Cellitron; Novartis AG; Pfizer; BIOCAD; Shanghai Henlius Biotech Inc. Rituximab Biosimilars Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Biologics Global Market Report 2024
... Drugs; Over-The-Counter Drugs 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores Covering: Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc. Biologics Global Market Report 2024 from ... Read More
Research Assistance
